Triphenyl phosphate exposure induces kidney structural damage and gut microbiota disorders in mice under different diets

被引:29
作者
Cui, Haiyan [1 ]
Chang, Yeqian [1 ]
Jiang, Xiaofeng [1 ]
Li, Mei [1 ]
机构
[1] Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resource Reuse, 163 Xianlin Ave, Nanjing 210023, Peoples R China
基金
中国国家自然科学基金;
关键词
Triphenyl phosphate; Kidney structural damage; Gut microbiota; High fructose and fat; 16S rRNA sequencing; ORGANOPHOSPHORUS FLAME RETARDANTS; NF-KAPPA-B; OXIDATIVE STRESS; LIPID-METABOLISM; RISK-ASSESSMENT; PLASTICIZERS; APOPTOSIS; FAT; LIPOTOXICITY; ENDOCRINE;
D O I
10.1016/j.envint.2020.106054
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Exposure of humans to organophosphate flame retardants (OPFRs) and the consequent health risk have increased owing to the latter's widespread application. Although triphenyl phosphate (TPP), an OPFR, is a potential chemical determinant of liver function damage, its effects on kidney function in mice under high fructose/fat (HFF) diet are still unclear. In this study, C57BL/6J mice were fed HFF to generate an obesity model and mice were exposed to low dose (0.01 mg/kg/day; TPP-L) and high dose (1 mg/kg/day; TPP-H) of TPP for 12 weeks. Results showed that TPP-L and TPP-H combined with HFF, as well as TPP-H alone, caused kidney structural damage and gut microbiota disorders in mice. Inflammatory response induced by nuclear factor kappa B (NF-kappa B p65)/nod-like receptor protein 3 (NLRP3) and caspase-3 promoted kidney structure damage, as well as accumulation of triglyceride and total cholesterol and the protein residues in urine. Although TPP-L did not cause obvious structural damage in the kidneys, 0.01 mg/kg TPP induced significant inflammation and gut microbiota disorders. These findings provide new insights regarding health risk assessment after chronic exposure to TPP and HFF alone, as well as a combination of TPP with HFF in mice.
引用
收藏
页数:12
相关论文
共 56 条
[1]   The Human Microbiome and Understanding the 16S rRNA Gene in Translational Nursing Science [J].
Ames, Nancy J. ;
Ranucci, Alexandra ;
Moriyama, Brad ;
Wallen, Gwenyth R. .
NURSING RESEARCH, 2017, 66 (02) :184-197
[2]  
Avenell A, 2004, HEALTH TECHNOL ASSES, V8, P1
[3]   Nlrp3 is a key modulator of diet-induced nephropathy and renal cholesterol accumulation [J].
Bakker, Pieter J. ;
Butter, Loes M. ;
Kors, Lotte ;
Teske, Gwendoline J. D. ;
Aten, Jan ;
Sutterwala, Fayyaz S. ;
Florquin, Sandrine ;
Leemans, Jaklien C. .
KIDNEY INTERNATIONAL, 2014, 85 (05) :1112-1122
[4]   Role of the Microbiota in Immunity and Inflammation [J].
Belkaid, Yasmine ;
Hand, Timothy W. .
CELL, 2014, 157 (01) :121-141
[5]   NLRP3 inflammasome expression is driven by NF-κB in cultured hepatocytes [J].
Boaru, Sorina Georgiana ;
Borkham-Kamphorst, Erawan ;
Van de Leur, Eddy ;
Lehnen, Eric ;
Liedtke, Christian ;
Weiskirchen, Ralf .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 458 (03) :700-706
[6]   Tracing organophosphorus and brominated flame retardants and plasticizers in an estuarine food web [J].
Brandsma, Sicco H. ;
Leonards, Pim E. G. ;
Leslie, Heather A. ;
de Boer, Jacob .
SCIENCE OF THE TOTAL ENVIRONMENT, 2015, 505 :22-31
[7]   Immunotoxicity of organophosphate flame retardants TPHP and TDCIPP on murine dendritic cells in vitro [J].
Canbaz, Derya ;
Logiantara, Adrian ;
van Ree, Ronald ;
van Rijt, Leonie S. .
CHEMOSPHERE, 2017, 177 :56-64
[8]   Triphenyl phosphate enhances adipogenic differentiation, glucose uptake and lipolysis via endocrine and noradrenergic mechanisms [J].
Cano-Sancho, German ;
Smith, Anna ;
La Merrill, Michele A. .
TOXICOLOGY IN VITRO, 2017, 40 :280-288
[9]   Caspase-3 is a pivotal mediator of apoptosis during regression of the ovarian corpus luteum [J].
Carambula, SF ;
Matikainen, T ;
Lynch, MP ;
Flavell, RA ;
Gonçalves, PBD ;
Tilly, JL ;
Rueda, BR .
ENDOCRINOLOGY, 2002, 143 (04) :1495-1501
[10]   Can the skin make you fat? A role for the skin in regulating adipose tissue function and whole-body glucose and lipid homeostasis [J].
Caton, Paul W. ;
Evans, Elizabeth A. ;
Philpott, Michael P. ;
Hannen, Rosalind F. .
CURRENT OPINION IN PHARMACOLOGY, 2017, 37 :59-64